JPMorgan Chase & Co. Has Lowered Expectations for Surgery Partners (NASDAQ:SGRY) Stock Price

Surgery Partners (NASDAQ:SGRY) had its price objective reduced by equities research analysts at JPMorgan Chase & Co. from $27.00 to $20.00 in a report released on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 18.41% from the company’s current price.

A number of other equities research analysts also recently issued reports on SGRY. Bank of America assumed coverage on Surgery Partners in a research report on Monday, July 28th. They set a “buy” rating and a $28.00 price target for the company. Royal Bank Of Canada reduced their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Cantor Fitzgerald reiterated an “overweight” rating and set a $36.00 target price on shares of Surgery Partners in a report on Tuesday, October 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research report on Monday, November 17th. Finally, UBS Group reduced their price target on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, November 13th. Seven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and an average price target of $27.44.

Surgery Partners Price Performance

Surgery Partners stock opened at $16.89 on Monday. Surgery Partners has a 1 year low of $14.94 and a 1 year high of $26.16. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93. The firm has a 50 day moving average price of $20.09 and a 200 day moving average price of $21.61. The company has a market cap of $2.18 billion, a price-to-earnings ratio of -11.81 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Monday, November 10th. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The company had revenue of $821.50 million during the quarter, compared to analyst estimates of $823.55 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.19 EPS. Surgery Partners has set its FY 2025 guidance at EPS. Sell-side analysts predict that Surgery Partners will post 0.67 earnings per share for the current year.

Insider Activity

In related news, insider Harrison R. Bane sold 9,339 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the sale, the insider directly owned 117,181 shares in the company, valued at approximately $2,634,228.88. This trade represents a 7.38% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in SGRY. Pentwater Capital Management LP increased its stake in Surgery Partners by 66.9% during the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after buying an additional 4,681,000 shares during the period. Vanguard Group Inc. raised its position in shares of Surgery Partners by 5.9% in the 3rd quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock valued at $164,778,000 after purchasing an additional 424,518 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Surgery Partners by 19.7% during the first quarter. Wellington Management Group LLP now owns 7,091,756 shares of the company’s stock worth $168,429,000 after buying an additional 1,165,667 shares in the last quarter. King Street Capital Management L.P. raised its holdings in Surgery Partners by 24.5% in the second quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock valued at $138,382,000 after acquiring an additional 1,225,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Surgery Partners by 25.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,860,215 shares of the company’s stock worth $105,177,000 after purchasing an additional 988,956 shares during the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.